Amlan International Names Beijing Zhongnong Pasture Biotechnology Co., Ltd. as Master Distributor in China
CHICAGO, June 01, 2023 (GLOBE NEWSWIRE) -- Amlan® International, the animal health business of Oil-Dri® Corporation of America and a global leader in mineral-based feed additives that optimize the intestinal health of poultry and livestock, is proud to announce its strategic restructuring plans for the China business. To streamline distribution and increase efficiency, Amlan has chosen Beijing Zhongnong Pasture Biotechnology Co., Ltd. as its master distributor in China.
The strategic decision recognizes the significance of the Chinese market and Amlan’s successful longstanding partnership with Zhongnong. In 2021, China had the world’s largest swine meat production, 53 million MT, producing 44% of global production. Additionally, China was the world’s second largest broiler meat producer, producing 14.7 million MT, and the world’s third largest milk producer, producing 36.8 million MT in the same year. With nearly 20 years of experience serving the Chinese feed and farming industry, Zhongnong has proven to be a valuable partner in the northern region of China by working closely with Amlan to provide proven mineral-based feed additives to Chinese animal producers.
Zhongnong has a highly professional sales team with widespread reach and a comprehensive service network, possessing an in-depth understanding and appreciation of Amlan's products. Leveraging this vast knowledge and industry experience will enhance the value delivered to customers in the Chinese market by improving distribution efficiency and promoting Amlan's full range of products, including Calibrin®-A and Calibrin®-Z products, and products, such as Varium® and NeoPrime®, that will be available in the future. Since 2012, Zhongnong has been one of Amlan’s top-performing distributors, fostering a long history of partnership, mutual trust, and support. Amlan and Zhongnong have full confidence in the market and sales prospects.
"We are extremely optimistic about Amlan's future prospects for global growth. Zhongnong has a distinct advantage in the China market with a strong and loyal ruminant and layer customer base that can accelerate Amlan’s business opportunities and support the business," said Dr. Wade Robey, Vice President of Agriculture, Oil-Dri Corporation of America, and President, Amlan International. By establishing Zhongnong as its master distributor, Amlan is poised to continue its growth and success in the Chinese market while providing value and support to both existing and future customers.
Oil-Dri Corporation of America doing business as “Amlan International” is a publicly traded company on the New York Stock Exchange (NYSE: ODC). Oil-Dri leverages over 80 years of expertise in mineral science to selectively mine and process their unique mineral for consumer and business-to-business markets. Amlan International sells feed additives across the world.
Product availability may vary by country, associated claims do not constitute medical claims and may differ based on government requirements.
VP, Strategic Marketing
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/5f47053e-1736-4253-8861-6e1c8eddf6beTo view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Northland Power Announces Signing of Credit Agreement for $5.0 Billion Project Financing at Hai Long Offshore Wind Project22.9.2023 05:42:30 CEST | Press release
Project Highlights Hai Long is a 1.0 gigawatt (GW) offshore wind project being developed as a joint venture between Northland (60 per cent) and Mitsui & Co. (40 per cent).The project is Northland’s first offshore wind project in Asia and fifth in Northland’s offshore wind portfolio.Hai Long 2A (294 MW) benefits from a 20-year PPA with Taipower, and Hai Long 2B and 3 (728 MW) benefits from a 30-year Corporate Power Purchase Agreement (CPPA) with an investment grade counterparty (S&P: AA-).Upon completion of Hai Long and the Baltic Power project, the company’s gross installed offshore wind capacity will nearly triple from 1.2 GW to 3.3 GW.The total capital cost of the project is projected to be approximately $9 billion. Northland has secured all necessary equity funding required for the project. Financial close is expected to follow shortly, upon satisfaction of all relevant conditions precedent to the financing being achieved.The project is expected to provide strong Free Cash Flow and
The Human Rights and Rights to Religious Freedom of 600,000 Japanese Citizens are at Risk22.9.2023 02:02:46 CEST | Press release
CESNUR - Human Rights and Religious Freedom Experts Decry Government Persecution of Minority Religion in Japan Washington, DC, Sept. 21, 2023 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE Center for Studies on New Religions, Human Rights and Religious Freedom Experts Decry Government Persecution of Minority Religion in Japan CESNUR’s Bitter Winter Magazine Posts Booklet Explaining Why Japanese Government Has No Legal Basis to Dissolve The Unification Church/Family Federation The Human Rights and Rights to Religious Freedom of 600,000 Japanese Citizens are at Risk TORINO, Italy (September 19, 2023)—Bitter Winter, a magazine of the Center for Studies on New Religions (CESNUR), has been following the Japanese government’s unusual and intrusive investigation of a minority religion, which started after the July 2022 assassination of Prime Minister Shinzo Abe. Today, Bitter Winter starts publishing a booklet that explains why the Japanese government has no legal basis to file for dissolution of
Adevinta ASA – Comment on press speculation21.9.2023 23:35:50 CEST | Press release
Oslo, 21 September 2023 – Adevinta ASA (“Adevinta” or the “Company”) notes the recent press speculation. Adevinta confirms that it has received a non-binding indicative proposal from a consortium led by Permira and Blackstone regarding a potential offer for all shares of the Company. eBay and Schibsted, who have expressed their support for the proposal, would retain part of their current shareholding in the Company. The discussions are at an early stage and there can be no certainty as to whether a final offer will be made, nor as to the terms of any offer. Shareholders are advised to refrain from taking any action in respect of their shares in the Company which may be prejudicial to their interests, and to exercise caution when dealing in the shares of the Company. A further announcement will be made as and when appropriate in compliance with applicable laws and regulations. This information is considered to include inside information pursuant to the EU Market Abuse Regulation article
CNH Industrial: Periodic Report on $300 Million Buyback Program21.9.2023 22:30:00 CEST | Press release
Basildon, September 21, 2023 CNH Industrial N.V. (NYSE: CNHI / MI: CNHI) announces that under the sixth $50 million tranche (the “Sixth Tranche”) of its $300 million share buyback program the Company completed transactions in the period September 12, 2023 to September 13, 2023, reported in aggregate, as set forth in the table below. After the purchases announced today and considering those previously executed under the Sixth Tranche, the total invested amount in the Sixth Tranche is approximately €16,899,590.93 ($18,387,060.25) or a total amount of 1,346,877 common shares purchased. DateNumber of common shares purchasedAverage price per share excluding feesConsideration excluding fees Consideration (*) excluding fees(€)(€)($) September 12, 2023 44,053 12.4883 550,147.08 589,372.57 September 13, 2023 78,000 12.4312 968,861.40 1,039,878.94 122,053 - 1,519,008.481,629,251.51 (*) All translations determined from Euro to US Dollar at the exchange rate reported by the European Central Bank o
PHAXIAM Provides Business and Financial Update For the First Half of 202321.9.2023 22:05:00 CEST | Press release
PHAXIAM Provides Business and Financial Update For the First Half of 2023 Conference call and webcast (English) on Monday, September 25, 2023 at 8:30am ET / 2:30pm CEST Formation of PHAXIAM Therapeutics effective as of June 23, 2023, to create a global leaderinphage therapiesfor high-value indicationsAmbitious strategyto develop value-creatingclinical and regulatory plan in severe and resistantbacterial infections Plan to launch new and first phase 2b/3 global pivotal study in Prosthetic Joint Infections (PJI) in 2H 2024Interactions with FDA (Pre-IND) and EMA (Scientific advice) planned in Q4 2023, to finalize the design of the Phase 2b/3 study in PJIPlan to launch Phase 1 study in Endocarditis Infections in Q4 2023Cash and cash equivalentsof €25.2 million ($27.5 million) as of June 30, 2023 Lyon (France) et Cambridge (MA, US), September 21, 2023 at 10:05pm CEST–PHAXIAM Therapeutics (Nasdaq & Euronext: PHXM),today provides a business and financial update for the first half of 2023. “Wi